BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15110052)

  • 1. Community-based screening for cardiovascular disease and diabetes using HbA1c.
    Grant T; Soriano Y; Marantz PR; Nelson I; Williams E; Ramirez D; Burg J; Nordin C
    Am J Prev Med; 2004 May; 26(4):271-5. PubMed ID: 15110052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of risk stratification to increase the predictive validity of HbA1c in screening for undiagnosed diabetes in the US population.
    Ginde AA; Cagliero E; Nathan DM; Camargo CA
    J Gen Intern Med; 2008 Sep; 23(9):1346-53. PubMed ID: 18543044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of point of care testing on diabetes services along Victoria's Mallee Track: results of a community-based diabetes risk assessment and management program.
    Shephard MD; Mazzachi BC; Shephard AK; McLaughlin KJ; Denner B; Barnes G
    Rural Remote Health; 2005; 5(3):371. PubMed ID: 16026194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point-of-care glucose and hemoglobin A1c in emergency department patients without known diabetes: implications for opportunistic screening.
    Ginde AA; Cagliero E; Nathan DM; Camargo CA
    Acad Emerg Med; 2008 Dec; 15(12):1241-7. PubMed ID: 18785943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hemoglobin A1c greater than 6.5% and 7.0% among hospitalized patients without known diagnosis of diabetes at an urban inner city hospital.
    Mazurek JA; Hailpern SM; Goring T; Nordin C
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1344-8. PubMed ID: 20080838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemoglobin A1c levels in diagnosed and undiagnosed black, Hispanic, and white persons with diabetes: results from NHANES 1999-2000.
    Boltri JM; Okosun IS; Davis-Smith M; Vogel RL
    Ethn Dis; 2005; 15(4):562-7. PubMed ID: 16259477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of HbA1c versus oral glucose tolerance test (OGTT) as a screening tool to diagnose dysglycemic status in high-risk Thai patients.
    Thewjitcharoen Y; Jones Elizabeth A; Butadej S; Nakasatien S; Chotwanvirat P; Wanothayaroj E; Krittiyawong S; Himathongkam T; Himathongkam T
    BMC Endocr Disord; 2019 Feb; 19(1):23. PubMed ID: 30770743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic threshold of HbA1c and impact of its use on diabetes prevalence-a population-based survey of 6898 Han participants from southern China.
    Huang H; Peng G; Lin M; Zhang K; Wang Y; Yang Y; Zuo Z; Chen R; Wang J
    Prev Med; 2013 Oct; 57(4):345-50. PubMed ID: 23777673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.
    Hu Y; Liu W; Chen Y; Zhang M; Wang L; Zhou H; Wu P; Teng X; Dong Y; Zhou Jw; Xu H; Zheng J; Li S; Tao T; Hu Y; Jia Y
    Acta Diabetol; 2010 Sep; 47(3):231-6. PubMed ID: 19760291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of the U.S. Preventive Services Task Force criteria for diabetes screening.
    Casagrande SS; Cowie CC; Fradkin JE
    Am J Prev Med; 2013 Aug; 45(2):167-74. PubMed ID: 23867023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardio-metabolic risk factors and prehypertension in persons without diabetes, hypertension, and cardiovascular disease.
    Chiang PP; Lamoureux EL; Shankar A; Tai ES; Wong TY; Sabanayagam C
    BMC Public Health; 2013 Aug; 13():730. PubMed ID: 23919264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Associations between glycated hemoglobin levels and atherosclerotic risk factors in urban communities].
    Furuya H; Nagaoka T; Mizushima S; Ito S; Shibata N; Okamoto N; Okazaki I
    Nihon Koshu Eisei Zasshi; 2002 Aug; 49(8):729-38. PubMed ID: 12355867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocytosis and Performance of HbA1c in Detecting Diabetes on an Oxygen-Deficient Plateau: A Population-based Study.
    Ren Q; Lv X; Yang L; Yue J; Luo Y; Zhou L; Meng S; Yang S; Puchi B; Zhou X; Ji L
    J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31904080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of a multi-level community-clinical linkage intervention to improve glycemic control among south Asian patients with uncontrolled diabetes: study protocol of the DREAM initiative.
    Lim S; Wyatt LC; Mammen S; Zanowiak JM; Mohaimin S; Troxel AB; Lindau ST; Gold HT; Shelley D; Trinh-Shevrin C; Islam NS
    BMC Endocr Disord; 2021 Nov; 21(1):233. PubMed ID: 34814899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of PRECEDE model for health education on changes and level of control of HbA1c, blood pressure, lipids, and body mass index in patients with type 2 diabetes mellitus.
    Salinero-Fort MA; Carrillo-de Santa Pau E; Arrieta-Blanco FJ; Abanades-Herranz JC; Martín-Madrazo C; Rodés-Soldevila B; de Burgos-Lunar C
    BMC Public Health; 2011 Apr; 11():267. PubMed ID: 21524316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemoglobin A1c as a marker for identifying diabetes and cardiovascular risk factors: the China Health and Nutrition Survey 2009.
    Sun X; Du T; Huo R; Xu L
    Acta Diabetol; 2014; 51(3):353-60. PubMed ID: 24072380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting Plasma Glucose and the HbA1c Are Not Optimal Screening Modalities for the Diagnosis of New Diabetes in Previously Undiagnosed Asian Indian Community Participants.
    Prakaschandra R; Naidoo DP
    Ethn Dis; 2018; 28(1):19-24. PubMed ID: 29467562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Undiagnosed diabetes: Prevalence and cardiovascular risk profile in a population-based study of 52,856 individuals. The HUNT Study, Norway.
    Bjarkø VV; Haug EB; Sørgjerd EP; Stene LC; Ruiz PL; Birkeland KI; Berg TJ; Gulseth HL; Iversen MM; Langhammer A; Åsvold BO
    Diabet Med; 2022 Jun; 39(6):e14829. PubMed ID: 35288977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for diabetes in Indigenous populations using glycated haemoglobin: sensitivity, specificity, post-test likelihood and risk of disease.
    Rowley KG; Daniel M; O'Dea K
    Diabet Med; 2005 Jul; 22(7):833-9. PubMed ID: 15975095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cardiovascular disease risk factor screening program designed to reach rural residents of Maine, USA.
    Harris DE; Hamel L; Aboueissa AM; Johnson D
    Rural Remote Health; 2011; 11(3):1-15. PubMed ID: 21834601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.